Goldman's The 720 focuses on China CDMO resilience and multi-sector rating changes

Overview

This is a Goldman Sachs Asian and global multi-theme research compilation covering China CDMO, China industrial technology, the Huaming upgrade, Japan real estate rating changes, China brokers, China sportswear, China energy, Japan semiconductor equipment, Yaskawa, Japan banks, Mitsubishi Electric, Lynas Rare Earths, Eternal, Japan Macro, Alphabet, and others. The central message is that fundamental resilience and structural growth continue to support selected sectors and stocks, but valuation, interest rates, foreign exchange, geopolitics, and channel changes are creating significant differentiation in return prospects.

Core views

For China CDMO, Goldman Sachs believes that 2Q fundamentals, orders, and demand for key technology modalities remain robust, and that the sustainability of the sector's recent re-rating depends on earnings delivery and order wins. For China industrial technology, AI infrastructure and factory automation are driving industry growth, but valuations for some highfliers are already demanding. Huaming was upgraded to Buy due to the global power-grid upgrade cycle and a higher share of high-margin exports. Japan real estate is rebalancing valuations amid rising interest rates and stronger office rents, resulting in multiple upgrades and downgrades. Among brokers, energy, semiconductor equipment, banks, and large technology companies, the report generally favors assets supported by structural demand, earnings upgrades, or order backlogs.

Analysis framework

The report combines top-down thematic assessment with bottom-up stock ratings: it first evaluates industry demand, orders, macro interest rates, energy supply and demand, policy, and capital-market conditions, and then maps these to earnings forecasts, target prices, and rating changes. Key variables include CDMO order and backlog conversion, industrial technology 2Q revenue and EPS growth, real estate capitalization rates and office rents, broker trading volumes and ROE, substitution and inventory buffers following lower energy imports, SEAJ data on semiconductor equipment, and evidence of returns on AI investment in cloud and advertising businesses.

Methodology notes

• equity_factor_frameworkGS Factor Profile

  Growth, financial returns, valuation multiples, and integrated percentile

  Goldman Sachs compares the relative positioning of stocks against the market and industry peers using four attributes: Growth, Financial Returns, Multiple, and Integrated. Growth is based on forward sales, EBITDA, and EPS growth; Financial Returns is based on ROE, ROCE, and CROCI; Multiple is based on valuation metrics including P/E, P/B, P/D, EV/EBITDA, and EV/FCF; and Integrated is a composite measure adjusted for growth, returns, and valuation.

• corporate_event_frameworkM&A Rank

  Probability score for potential acquisition targets

  Goldman Sachs evaluates the likelihood that covered companies will become acquisition targets using qualitative and quantitative factors, assigning an M&A rank from 1 to 3: 1 represents a high probability, 2 a medium probability, and 3 a low probability. When the rank is 1 or 2, M&A factors may be incorporated into the target price.

• rating_frameworkGoldman Sachs Buy/Neutral/Sell

  Total-return potential relative to the coverage universe

  Buy or Sell indicates that a stock is included in the regional Investment Lists, depending on its total-return potential relative to the coverage universe. Stocks not included as Buy or Sell but still carrying a valid rating are considered Neutral. Target prices generally correspond to a 12-month horizon and consider the difference between the price target and total returns from expected dividends.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Wuxi AppTec / China CDMO sector

  Positively correlated with demand for GLP-1, ADC, and AI drug discovery, as well as order backlog conversion

  Strengths

  Resilient order momentum, sustained demand for key technology modalities, and upgrades to some earnings forecasts.

  Weaknesses

  The sector has recently been re-rated, so continued earnings and order delivery is required.

  Comparison

  Compared with manufacturing sectors driven by a single cycle, CDMO depends more on outsourced pharmaceutical R&D and the depth of its technology platforms.

  Risks

  Foreign-exchange headwinds, geopolitical noise, and lower-than-expected order conversion.

• China industrial technology

  Benefits from AI infrastructure and factory automation, but valuation differentiation is intensifying

  Strengths

  2Q revenue and EPS growth are expected to accelerate, while data-center demand and market-share gains support selected leaders.

  Weaknesses

  Weakness in China's EV and solar sectors offsets some growth, and positive expectations for highfliers may already be reflected.

  Comparison

  Goldman Sachs favors companies such as Inovance, Hongfa, and Techtronic, which offer a better balance between growth and valuation, rather than names that have risen sharply since the start of the year and carry excessive expectations.

  Risks

  Valuation corrections, slower downstream capital expenditure, and overly high market-share expectations.

• Huaming

  Defensive participation in the global power-grid upgrade cycle

  Strengths

  Valuation is attractive after the share-price pullback; aging grids, renewable-energy integration, and rising overseas share provide multiyear demand.

  Weaknesses

  The target price was not raised, and some benefits still need to be realized through a higher export share and improved margins.

  Comparison

  Compared with higher-volatility industrial growth stocks, Huaming is described as offering more defensive exposure to power-grid upgrades.

  Risks

  Weaker-than-expected overseas orders, slower-than-expected growth in the high-margin export share, and a slowdown in global grid investment.

• Japan real estate

  Affected simultaneously by rising interest rates and higher Tokyo office rents

  Strengths

  Tight office supply and corporate demand support rent growth, while NAV discounts at some companies are attractive.

  Weaknesses

  Higher capitalization rates and mortgage rates pressure valuations and residential sales.

  Comparison

  Tokyu Fudosan HD, Daiwa Office Investment, and Mori Hills REIT have relatively improved prospects, while Sumitomo Realty & Development and Sekisui House REIT are relatively weaker.

  Risks

  Further increases in Japanese interest rates, slower residential sales, and an inability to narrow NAV discounts.

• China brokers and asset managers

  Benefits from capital-market activity, Hong Kong expansion, A-share technology IPOs, and industry consolidation

  Strengths

  Revenue and earnings forecasts were raised, leading brokers' ROE is improving, and CICC, GFS, and CITICS remain Buy-rated.

  Weaknesses

  Performance will diverge across business models, while low-cost fund-distribution moats may be weakened by the ETF trend.

  Comparison

  Leading brokers are preferred over East Money.

  Risks

  A decline in trading volumes, slower IPO activity, wealth-management fee pressure, and weaker-than-expected integration synergies.

• Alphabet

  Returns on AI investment are reflected through Cloud, Search, and YouTube Ads performance

  Strengths

  Q2 revenue and operating profit exceeded expectations; Google Cloud revenue grew 82% year on year, with cloud margins in the mid-30% range.

  Weaknesses

  There is no new guidance for 2026 and 2027 capital expenditure, and the market remains focused on AI investment intensity.

  Comparison

  Compared with technology companies that have yet to prove returns from AI commercialization, Alphabet's quarterly results provide strong validation.

  Risks

  Rising AI capital expenditure, changes in Gemini's competitive position, and slower digital advertising demand.

Key data

• China CDMO earnings forecast upgradesFY26-28E adjusted net profit forecasts raised by 5%/10%/6%Applies to some covered companies and reflects 2Q fundamental resilience, order momentum, and demand for GLP-1, ADC, and AI drug discovery.
• China CDMO target-price adjustments12-month target prices raised by an average of 5%Goldman Sachs remains bullish on Wuxi AppTec and focuses on backlog conversion and order momentum at WuXi AppTec, Asymchem, Pharmaron, Tigermed, and GenScript.
• China industrial technology 2Q previewRevenue up 18% year on year, EPS up 12% year on yearGrowth is strongly driven by AI infrastructure and factory automation, partly offset by weakness in China's EV and solar sectors.
• Huaming rating and target priceUpgraded to Buy, with a 12-month target price of Rmb23.9The share price recently pulled back 36%; global power-grid upgrades and a higher export share support 2026E-30E revenue CAGR of 14% and net profit CAGR of 17%.
• Japan real estate assumption adjustmentsCapitalization-rate assumptions raised by 90bp; Tokyo office rents expected to grow 9.0%/10.4% in 2026/2027Upgrades and downgrades occurred simultaneously, reflecting changes in interest rates, rent growth, NAV discounts, and relative valuations.
• China broker earnings forecasts2026-2027 revenue and earnings forecasts raised by an average of 9% and 13%Driven by high trading volumes, Hong Kong expansion, A-share technology IPOs, industry consolidation, and technology investment; estimated ROE for leading companies was raised by 145bp to 11.2%.
• Resilience of China energy demandTotal energy demand still grew slightly by 0.4% year on year in April-MayFollowing lower oil and gas imports, inventory drawdowns of coal, oil products, and natural gas, along with substitution toward coal and renewables, buffered the shock.
• Japan semiconductor equipment demandAverage monthly sales of ¥513.6bn in April-June 2026, up 27% year on yearSEAJ raised its FY3/27 demand forecast to ¥6.55tn, up 26% year on year, and forecasts ¥7.40tn for FY3/28, up 13% year on year.
• Yaskawa operating guidanceFull-year operating profit guidance of ¥60bn versus Goldman Sachs' forecast of ¥64bnERP-related production disruptions are normalizing as expected; inverter utilization exceeds 100%, while servo motors and robots are at approximately 70%.
• Alphabet Q2 resultsTotal revenue of $119.8bn, up 24% year on year; GAAP operating profit of $40.8bnSearch, YouTube Ads, and Google Cloud exceeded expectations, with Google Cloud revenue up 82% year on year.

Impact & implications

The investment implication is that Asian equity opportunities are shifting from simple sector beta toward earnings delivery, valuation discipline, and thematic quality selection. China CDMO, selected industrial automation, power-grid equipment, brokers, semiconductor equipment, and AI cloud services still have positive catalysts; however, greater caution is warranted in highflying industrial technology names, Japan real estate names constrained by interest rates or with limited upside, and sportswear distributors affected by Nike's online-channel reforms. At the macro level, Japan's shift toward multiyear investment budgets and China's energy system buffering external shocks through inventories and fuel substitution both suggest that policy and industrial-structure changes will continue to affect asset performance.

Risks

• Following the re-rating of China's CDMO sector, valuations could retreat if order wins or backlog conversion fall short of expectations.
• Foreign-exchange headwinds and geopolitical noise could reduce earnings visibility for China CDMO and industrial technology companies.
• Earnings and market-share expectations for some highflying China industrial technology names may be overly optimistic.
• Further increases in Japanese interest rates could push capitalization rates higher, weighing on real estate valuations and housing affordability.
• Nike's online-channel reforms in China could intensify promotional and inventory pressure in the sportswear industry.
• Uncertainty in the Middle East could create downside risks for Japanese banks and energy-related industries.
• If AI capital expenditure continues to rise while returns slow, valuations of large technology companies could be affected.

What to watch

• 2Q results, order wins, and backlog conversion at China CDMO companies.
• Whether demand related to GLP-1, ADC, and AI drug discovery remains sustained.
• China industrial technology 2Q revenue and EPS delivery, as well as AI infrastructure and factory automation orders.
• Huaming's export share, overseas market share, and global power-grid upgrade orders.
• Japanese office rents, capitalization rates, the interest-rate path, and changes in residential sales.
• China brokers' second-half trading volumes, the pace of A-share technology IPOs, Hong Kong capital deployment, and industry M&A.
• China's energy imports, inventory drawdowns, and the intensity of coal and renewable-energy substitution.
• SEAJ semiconductor equipment data, HBM and advanced-logic demand, and changes in USD/JPY assumptions.
• Alphabet's subsequent AI capital expenditure, Gemini's competitive landscape, and advertising demand.